Diplomat Pharmacy buy melinda
Start price
25.08.18
/
50%
€17.73
Target price
02.11.18
€19.84
Performance (%)
7.48%
End price
02.11.18
€19.06
Summary
This prediction ended on 02.11.18 with a price of €19.06. With a performance of 7.48%, the BUY prediction by melinda for Diplomat Pharmacy closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Diplomat Pharmacy | - | - | - | - |
| iShares Core DAX® | -0.315% | -2.776% | 12.361% | 15.821% |
| iShares Nasdaq 100 | 1.250% | 7.480% | 34.131% | 57.547% |
| iShares Nikkei 225® | -1.284% | -2.199% | 5.146% | 3.302% |
| iShares S&P 500 | 1.141% | 4.717% | 28.724% | 51.350% |
Comments by melinda for this prediction
In the thread Diplomat Pharmacy diskutieren
SecteurInstallations et services en soins de santé Agenda 12/09 | 17:40 Présentation
Diplomat Pharmacy, Inc. engages in the provision of pharmacy services.
It focuses on improving the lives of patients with complex chronic diseases while delivering solutions for manufacturers, hospitals, payers, and providers.The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.
Nombre d'employés : 2 419 personnes.